How Crohn’s Disease Impacts Fertility: What Patients Need to Know

Understanding the relationship between Crohn’s disease and reproductive health is essential for anyone planning a family. While many individuals with Crohn’s conceive without difficulty, certain factors—such as inflammation, nutrition, medication, and surgery—can influence fertility and pregnancy outcomes.

Current Evidence on Fertility Rates

A 2021 systematic review found that women with inflammatory bowel disease (IBD), including Crohn’s and ulcerative colitis, have fertility rates comparable to the general population. However, they face higher risks of pre‑term delivery and cesarean section.

A Swedish cohort study published in 2021 reported slightly lower fertility among women with Crohn’s disease, with infertility rates ranging from 3 % to 14 %. These figures overlap the 2.4 %–14 % infertility range observed in women without Crohn’s, suggesting that the overall impact is modest.

For men, most researchers agree that well‑controlled Crohn’s disease does not diminish fertility. The notable exception is the medication sulfasalazine, which can temporarily lower sperm count and motility. Sperm parameters typically return to normal after discontinuing the drug for several months.

Factors That May Influence Fertility

• Inflammation: Active disease, especially pelvic inflammation, can impair conception.
• Nutritional deficiencies: Deficits in iron, folate, zinc, or vitamin D may affect reproductive function.
• Medications: Apart from sulfasalazine, most modern therapies (e.g., biologics) are considered safe for pregnancy and do not harm sperm quality.
• Surgery: Procedures such as colon resection can create scar tissue near reproductive organs, potentially reducing fertility in women.

Pregnancy Considerations for Women with Crohn’s

Even when disease is in remission at conception, flares can occur during pregnancy. Maintaining an active treatment plan under the guidance of a gastroenterologist is crucial to minimize complications for both mother and baby.

Male Fertility and Crohn’s Medications

A 2019 review of 14 studies highlighted a lack of high‑quality data on male fertility across all IBD types. Nevertheless, available evidence suggests that most men with Crohn’s have normal sperm parameters, except when taking sulfasalazine. Switching to an alternative therapy usually restores sperm health within a few months.

Choosing a Child‑Free Life

Some individuals with Crohn’s may decide against parenthood due to perceived health risks. Research indicates that misconceptions about fertility often drive these choices. It’s important to respect personal decisions while providing accurate, evidence‑based information.

Key Takeaways

• Well‑managed Crohn’s disease generally does not reduce fertility in men or women.
• Medication such as sulfasalazine can temporarily affect male sperm; alternative treatments are available.
• Surgical interventions and uncontrolled pelvic inflammation may lower a woman’s chance of conceiving.
• Pregnancy planning should involve a gastroenterologist to tailor treatment and monitor disease activity.

Because research is ongoing, anyone considering pregnancy should discuss personal risk factors and preparation strategies with their healthcare team.